The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes
To explore whether regularly reviewing one's own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits. Adults with type 1 diabetes ( = 300) or insulin-using type 2 diabetes ( = 198) using the Dexcom G5 Mobile or G6 R...
Gespeichert in:
Veröffentlicht in: | Diabetes technology & therapeutics 2022-07, Vol.24 (7), p.492-501 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 501 |
---|---|
container_issue | 7 |
container_start_page | 492 |
container_title | Diabetes technology & therapeutics |
container_volume | 24 |
creator | Polonsky, William H Soriano, Emily C Fortmann, Addie L |
description | To explore whether regularly reviewing one's own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits.
Adults with type 1 diabetes (
= 300) or insulin-using type 2 diabetes (
= 198) using the Dexcom G5 Mobile or G6 Real-Time CGM (RT-CGM) system and receiving the weekly CLARITY summary report of their glucose data completed a survey exploring their use of the report and its perceived value and impact on QoL and glycemic outcomes. Regression analyses examined whether personal use of the report was associated with QoL, perceived glycemic outcomes, and RT-CGM metrics.
The majority reported that receiving and viewing the report contributed to improved hypoglycemic confidence (75.9%) and overall well-being (50.0%), reduced diabetes distress (59.3%-74.1%), and helped to improve A1C (73.1%) and reduce problems with hypoglycemia (61.8%) and chronic hyperglycemia (73.1%). Regularly reviewing the report with family or friends (positive predictor) and doing nothing with the report's information (negative predictor) were independently associated with QoL and perceived glycemic outcomes. Surprisingly, both predictors were also associated with poorer glycemic control (e.g., greater % time above range >180).
These findings suggest that receiving a weekly RT-CGM summary report may contribute to QoL and health benefits, especially if the individual chooses to actively review and make use of the report's findings and openly reviews the findings with family or friends. Prospective studies are needed to more precisely determine how retrospective RT-CGM data summaries can best be presented and utilized effectively by adults with diabetes to enhance health outcomes. |
doi_str_mv | 10.1089/dia.2021.0526 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2637320482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2682853081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-3b79282001659a5852135a006baa45f06182cf56fd199c725e3987d53110144d3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EoqVw5IosceGSZWxnEocbWkpbaVE_tD1HXmdCXSX2Ejut-mP4rzjqwoGTLfuZR5r3Zey9gJUA3XzunFlJkGIFKKsX7Fgg1oXGRr1c7hKKRmB1xN7EeA8AtZLiNTtSKBGlLI_Z7-0d8ZswEA89v6E0hbgnm9wD8W8mmfz04OiRO89TBq9oisGbgd_Gw4AZiq0bia-DT87PYY78bJhtyP8_gncpTM7__LIMWsrSjl-Me2MTD55fz2Zw6WnxbFxP3PiOn2dhuuOXc7JhpPiWverNEOnd4Txht99Pt-vzYnN5drH-uils3icValc3UksAUWFjUKMUCg1AtTOmxB4qoaXtseo70TS2lkiq0XWHSggQZdmpE_bp2bufwq-ZYmpHFy0Ng_GUV2plpXJyUGqZ0Y__ofdhnnImC6WlRgVaZKp4pmwONE7Ut_vJjWZ6agW0S29t7q1demuX3jL_4WCddyN1_-i_Rak_mPiSAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2682853081</pqid></control><display><type>article</type><title>The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes</title><source>Alma/SFX Local Collection</source><creator>Polonsky, William H ; Soriano, Emily C ; Fortmann, Addie L</creator><creatorcontrib>Polonsky, William H ; Soriano, Emily C ; Fortmann, Addie L</creatorcontrib><description>To explore whether regularly reviewing one's own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits.
Adults with type 1 diabetes (
= 300) or insulin-using type 2 diabetes (
= 198) using the Dexcom G5 Mobile or G6 Real-Time CGM (RT-CGM) system and receiving the weekly CLARITY summary report of their glucose data completed a survey exploring their use of the report and its perceived value and impact on QoL and glycemic outcomes. Regression analyses examined whether personal use of the report was associated with QoL, perceived glycemic outcomes, and RT-CGM metrics.
The majority reported that receiving and viewing the report contributed to improved hypoglycemic confidence (75.9%) and overall well-being (50.0%), reduced diabetes distress (59.3%-74.1%), and helped to improve A1C (73.1%) and reduce problems with hypoglycemia (61.8%) and chronic hyperglycemia (73.1%). Regularly reviewing the report with family or friends (positive predictor) and doing nothing with the report's information (negative predictor) were independently associated with QoL and perceived glycemic outcomes. Surprisingly, both predictors were also associated with poorer glycemic control (e.g., greater % time above range >180).
These findings suggest that receiving a weekly RT-CGM summary report may contribute to QoL and health benefits, especially if the individual chooses to actively review and make use of the report's findings and openly reviews the findings with family or friends. Prospective studies are needed to more precisely determine how retrospective RT-CGM data summaries can best be presented and utilized effectively by adults with diabetes to enhance health outcomes.</description><identifier>ISSN: 1520-9156</identifier><identifier>EISSN: 1557-8593</identifier><identifier>DOI: 10.1089/dia.2021.0526</identifier><identifier>PMID: 35255224</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Clinical outcomes ; Diabetes ; Glucose monitoring ; Quality of life ; Sensors ; Well being</subject><ispartof>Diabetes technology & therapeutics, 2022-07, Vol.24 (7), p.492-501</ispartof><rights>Copyright Mary Ann Liebert, Inc. Jul 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-3b79282001659a5852135a006baa45f06182cf56fd199c725e3987d53110144d3</citedby><cites>FETCH-LOGICAL-c321t-3b79282001659a5852135a006baa45f06182cf56fd199c725e3987d53110144d3</cites><orcidid>0000-0001-9064-6144</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35255224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polonsky, William H</creatorcontrib><creatorcontrib>Soriano, Emily C</creatorcontrib><creatorcontrib>Fortmann, Addie L</creatorcontrib><title>The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes</title><title>Diabetes technology & therapeutics</title><addtitle>Diabetes Technol Ther</addtitle><description>To explore whether regularly reviewing one's own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits.
Adults with type 1 diabetes (
= 300) or insulin-using type 2 diabetes (
= 198) using the Dexcom G5 Mobile or G6 Real-Time CGM (RT-CGM) system and receiving the weekly CLARITY summary report of their glucose data completed a survey exploring their use of the report and its perceived value and impact on QoL and glycemic outcomes. Regression analyses examined whether personal use of the report was associated with QoL, perceived glycemic outcomes, and RT-CGM metrics.
The majority reported that receiving and viewing the report contributed to improved hypoglycemic confidence (75.9%) and overall well-being (50.0%), reduced diabetes distress (59.3%-74.1%), and helped to improve A1C (73.1%) and reduce problems with hypoglycemia (61.8%) and chronic hyperglycemia (73.1%). Regularly reviewing the report with family or friends (positive predictor) and doing nothing with the report's information (negative predictor) were independently associated with QoL and perceived glycemic outcomes. Surprisingly, both predictors were also associated with poorer glycemic control (e.g., greater % time above range >180).
These findings suggest that receiving a weekly RT-CGM summary report may contribute to QoL and health benefits, especially if the individual chooses to actively review and make use of the report's findings and openly reviews the findings with family or friends. Prospective studies are needed to more precisely determine how retrospective RT-CGM data summaries can best be presented and utilized effectively by adults with diabetes to enhance health outcomes.</description><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Glucose monitoring</subject><subject>Quality of life</subject><subject>Sensors</subject><subject>Well being</subject><issn>1520-9156</issn><issn>1557-8593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi0EoqVw5IosceGSZWxnEocbWkpbaVE_tD1HXmdCXSX2Ejut-mP4rzjqwoGTLfuZR5r3Zey9gJUA3XzunFlJkGIFKKsX7Fgg1oXGRr1c7hKKRmB1xN7EeA8AtZLiNTtSKBGlLI_Z7-0d8ZswEA89v6E0hbgnm9wD8W8mmfz04OiRO89TBq9oisGbgd_Gw4AZiq0bia-DT87PYY78bJhtyP8_gncpTM7__LIMWsrSjl-Me2MTD55fz2Zw6WnxbFxP3PiOn2dhuuOXc7JhpPiWverNEOnd4Txht99Pt-vzYnN5drH-uils3icValc3UksAUWFjUKMUCg1AtTOmxB4qoaXtseo70TS2lkiq0XWHSggQZdmpE_bp2bufwq-ZYmpHFy0Ng_GUV2plpXJyUGqZ0Y__ofdhnnImC6WlRgVaZKp4pmwONE7Ut_vJjWZ6agW0S29t7q1demuX3jL_4WCddyN1_-i_Rak_mPiSAA</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Polonsky, William H</creator><creator>Soriano, Emily C</creator><creator>Fortmann, Addie L</creator><general>Mary Ann Liebert, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9064-6144</orcidid></search><sort><creationdate>20220701</creationdate><title>The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes</title><author>Polonsky, William H ; Soriano, Emily C ; Fortmann, Addie L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-3b79282001659a5852135a006baa45f06182cf56fd199c725e3987d53110144d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Glucose monitoring</topic><topic>Quality of life</topic><topic>Sensors</topic><topic>Well being</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polonsky, William H</creatorcontrib><creatorcontrib>Soriano, Emily C</creatorcontrib><creatorcontrib>Fortmann, Addie L</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes technology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polonsky, William H</au><au>Soriano, Emily C</au><au>Fortmann, Addie L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes</atitle><jtitle>Diabetes technology & therapeutics</jtitle><addtitle>Diabetes Technol Ther</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>24</volume><issue>7</issue><spage>492</spage><epage>501</epage><pages>492-501</pages><issn>1520-9156</issn><eissn>1557-8593</eissn><abstract>To explore whether regularly reviewing one's own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits.
Adults with type 1 diabetes (
= 300) or insulin-using type 2 diabetes (
= 198) using the Dexcom G5 Mobile or G6 Real-Time CGM (RT-CGM) system and receiving the weekly CLARITY summary report of their glucose data completed a survey exploring their use of the report and its perceived value and impact on QoL and glycemic outcomes. Regression analyses examined whether personal use of the report was associated with QoL, perceived glycemic outcomes, and RT-CGM metrics.
The majority reported that receiving and viewing the report contributed to improved hypoglycemic confidence (75.9%) and overall well-being (50.0%), reduced diabetes distress (59.3%-74.1%), and helped to improve A1C (73.1%) and reduce problems with hypoglycemia (61.8%) and chronic hyperglycemia (73.1%). Regularly reviewing the report with family or friends (positive predictor) and doing nothing with the report's information (negative predictor) were independently associated with QoL and perceived glycemic outcomes. Surprisingly, both predictors were also associated with poorer glycemic control (e.g., greater % time above range >180).
These findings suggest that receiving a weekly RT-CGM summary report may contribute to QoL and health benefits, especially if the individual chooses to actively review and make use of the report's findings and openly reviews the findings with family or friends. Prospective studies are needed to more precisely determine how retrospective RT-CGM data summaries can best be presented and utilized effectively by adults with diabetes to enhance health outcomes.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>35255224</pmid><doi>10.1089/dia.2021.0526</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9064-6144</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1520-9156 |
ispartof | Diabetes technology & therapeutics, 2022-07, Vol.24 (7), p.492-501 |
issn | 1520-9156 1557-8593 |
language | eng |
recordid | cdi_proquest_miscellaneous_2637320482 |
source | Alma/SFX Local Collection |
subjects | Clinical outcomes Diabetes Glucose monitoring Quality of life Sensors Well being |
title | The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Retrospective%20Data%20Review%20in%20the%20Personal%20Use%20of%20Real-Time%20Continuous%20Glucose%20Monitoring:%20Perceived%20Impact%20on%20Quality%20of%20Life%20and%20Health%20Outcomes&rft.jtitle=Diabetes%20technology%20&%20therapeutics&rft.au=Polonsky,%20William%20H&rft.date=2022-07-01&rft.volume=24&rft.issue=7&rft.spage=492&rft.epage=501&rft.pages=492-501&rft.issn=1520-9156&rft.eissn=1557-8593&rft_id=info:doi/10.1089/dia.2021.0526&rft_dat=%3Cproquest_cross%3E2682853081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2682853081&rft_id=info:pmid/35255224&rfr_iscdi=true |